WorldQuant Millennium Advisors
RARE icon

WorldQuant Millennium Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

WorldQuant Millennium Advisors’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.15M Buy
150,587
+53,679
+55% +$1.21M 0.01% 380
2025
Q4 		$2.23M Buy
+96,908
New +$3.19M 0.01% 418

Other funds holding RARE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

WorldQuant Millennium Advisors's RARE Position: Q1 2026 in Review

WorldQuant Millennium Advisors increased its Ultragenyx Pharmaceutical (RARE) stake by 55% in Q1 2026, buying an estimated $1.21M and bringing the position to 150,587 shares worth $3.15M. The position accounts for 0.01% of the portfolio, ranked #380.

WorldQuant Millennium Advisors first reported a position in RARE in Q4 2025 and has held it in 2 quarters since. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • WorldQuant Millennium Advisors held 150,587 shares of Ultragenyx Pharmaceutical worth $3.15M as of Q1 2026.
  • WorldQuant Millennium Advisors bought 53,679 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $1.21M.
  • Ultragenyx Pharmaceutical made up 0.01% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #380 holding.
  • WorldQuant Millennium Advisors first reported a position in Ultragenyx Pharmaceutical in Q4 2025 and has held it in 2 quarters since.
  • 295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.